Skip to main content
Mary Hammes, DO, Nephrology, Chicago, IL

Mary S Hammes DO

Chronic Renal Failure & Dialysis


Associate Professor of Medicine, University of Chicago Medicine

Join to View Full Profile
  • 5841 S Maryland AveChicago, IL 60637

  • Phone+1 888-824-0200

  • Fax+1 773-702-5818

Dr. Hammes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Mary Hammes is a nephrologist in Riverside, IL and is affiliated with University of Chicago Medical Center. She received her medical degree from Texas College of Osteopathic Medicine and has been in practice 29 years. She specializes in chronic renal failure & dialysis and is experienced in dialysis, continuous renal replacement therapy, peritoneal dialysis, and hemodialysis.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Nephrology, 1992 - 1995
  • Loyola University Medical Center
    Loyola University Medical CenterResidency, Internal Medicine, 1989 - 1992
  • Texas College of Osteopathic Medicine
    Texas College of Osteopathic MedicineClass of 1988

Certifications & Licensure

  • IL State Medical License
    IL State License 1990 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Nephrology
    American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • FDA Approves Terumo Aortic’s RelayPro Thoracic Stent Graft
    FDA Approves Terumo Aortic’s RelayPro Thoracic Stent GraftAugust 6th, 2021
  • Fist Assist Devices, LLC Announces Completion of the Non-Significant Risk FACT Trial
    Fist Assist Devices, LLC Announces Completion of the Non-Significant Risk FACT TrialAugust 4th, 2021
  • An Open Letter to UGA President Morehead on Safely Restarting Classes
    An Open Letter to UGA President Morehead on Safely Restarting ClassesJuly 7th, 2020
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: